Literature DB >> 26958679

CHRONIC PANCREATITIS IN A PATIENT WITH THE p.Asn34Ser HOMOZYGOUS SPINK1 MUTATION--OWN EXPERIENCE.

Agnieszka Magdalena Rygiel, Małgorzata Wojnicka-Stolarz, Katarzyna Niepokój, Grzegorz Oracz, Jerzy Bal, Katarzyna Wertheim-Tysarowska, Krzysztof Gutkowski.   

Abstract

Chronic pancreatitis (CP) is characterized by progressive damage to the exocrine and endocrine cell structures and pancreatic ducts with subsequent fibrosis of the organ. Patients with no apparent etiological factor are classified as having idiopathic CP (ICP). Genetic studies indicate the importance of mutations in the serine protease inhibitor, Kazal type 1 gene (SPINK1) in the pathogenesis of CP This report describes a case of a 29-year-old Polish-Vietnamese patient with the p.Asn34Ser (p.N34S) homozygous mutation in the SPINK1 gene. The patient was hospitalized due to pain of average intensity in the epigastric area which occurred for the first time in his life. Imaging examination showed the atrophy of the pancreatic parenchyma with the presence of numerous small calcifications and a single calcified lodgement with a diameter of 22 mm in the distal segment of Wirsung 's duct. Clinical interview did not reveal any obvious etiological pancreatitis risk factors implying the causative role of the p.Asn34Ser homozygous mutation of SPINK1 in this case as proven in our investigation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26958679

Source DB:  PubMed          Journal:  Dev Period Med


  2 in total

1.  Chronic pancreatitis caused by a Homozygous SPINK1 c.194 + 2T > C variant and Pancreas Divisum in a 3-year-old child-case report.

Authors:  Katarzyna Zdanowicz; Miroslawa Uscinowicz; Magdalena Rakowska; Katarzyna Wertheim-Tysarowska; Agnieszka Magdalena Rygiel; Grzegorz Oracz; Dariusz Marek Lebensztejn
Journal:  J Pediatr Genet       Date:  2020-10-05

Review 2.  Genetic Risk Factors in Early-Onset Nonalcoholic Chronic Pancreatitis: An Update.

Authors:  Katarzyna Wertheim-Tysarowska; Grzegorz Oracz; Agnieszka Magdalena Rygiel
Journal:  Genes (Basel)       Date:  2021-05-20       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.